Abiopharma

🔍 Cullum Charles S (Executive)

Company: SHORE BANCSHARES INC (SHBI)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 1,581 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,329.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 533 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 3,796.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,581 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 27,934.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4, F5

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: Shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of RSUs; no shares were sold by the reporting person.
• F3: Each restricted stock unit represents a contingent right to receive one share of SHBI common stock.
• F4: These restricted stock units vested on August 21, 2026.
• F5: Represents restricted stock units that vest as follows: 4,162 units on July 29, 2027; 4,162 units on July 29, 2028; 1,581 units on August 21, 2027; 1,582 units on August 21, 2028; 4,190 units on November 19, 2026; 4,190 units on November 19, 2027; 4,191 units on November 19, 2028; 1,292 units on February 17, 2027; 1,292 units on February 17, 2028; and 1,292 units on February 17, 2029.